Ethyl 8-benzyl-3-(3-cyclopentyloxy-4-methoxyphenyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-4-carboxylate
C29H36N2O5 — CID 11648884
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 8-benzyl-3-(3-cyclopentyloxy-4-methoxyphenyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-4-carboxylate
Ethyl 8-benzyl-3-(3-cyclopentyloxy-4-methoxyphenyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-4-carboxylate (PubChem CID 11648884) has the molecular formula C29H36N2O5 and a molecular weight of 492.62 g/mol. Its IUPAC name is ethyl 8-benzyl-3-(3-cyclopentyloxy-4-methoxyphenyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-4-carboxylate.
Molecular Properties
| Compound Name | Ethyl 8-benzyl-3-(3-cyclopentyloxy-4-methoxyphenyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-4-carboxylate |
|---|---|
| PubChem CID | 11648884 |
| Molecular Formula | C29H36N2O5 |
| Molecular Weight | 492.62 g/mol |
| Exact Mass | 492.26 |
| IUPAC Name | ethyl 8-benzyl-3-(3-cyclopentyloxy-4-methoxyphenyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-4-carboxylate |
| SMILES | CCOC(=O)C1C(c2ccc(OC)c(OC3CCCC3)c2)=NOC12CCN(Cc1ccccc1)CC2 |
| InChI | InChI=1S/C29H36N2O5/c1-3-34-28(32)26-27(22-13-14-24(33-2)25(19-22)35-23-11-7-8-12-23)30-36-29(26)15-17-31(18-16-29)20-21-9-5-4-6-10-21/h4-6,9-10,13-14,19,23,26H,3,7-8,11-12,15-18,20H2,1-2H3 |
| InChIKey | QCYSONPWVNTGIP-UHFFFAOYSA-N |
| XLogP | 4.97 |
| TPSA | 69.59 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 492.62 |
| LogP ≤ 5 | 4.97 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11648884 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.